Max MyHealth -by Max Hospitals vs TNM Cancer Staging System Kullanım & İstatistikleri

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content. TNM Cancer Staging System remains the gold standard reference for oncologists, surgeons, pathologists, radiologists, cancer registrars, & medical professionals worldwide to ensure that all those caring for cancer patients are fully versed in the language of cancer staging. This mobile resource includes Interactive TNM calculators that help proper classification and staging of cancer. *Breast cancer *Colon and Rectum *Distal Bile Duct *Liver *Neuroendocrine Tumors *Perihilar Bile Ducts *Stomach + Many others The TNM Cancer Staging System by AJCC is used by physicians & healthcare professionals throughout the world to facilitate the uniform description & reporting of neoplastic diseases. Proper classification and staging of cancer are essential for the physician to assign proper treatment, evaluate results of management and clinical trials, & serve as the standard for local, regional & international reporting on cancer incidence & outcome. Significantly expanded and developed by international disease site expert panels, this edition features 12 entirely new staging systems, a wide range of changed or new staging definitions, & a refined emphasis on a personalized-medicine approach. UPDATED CONTENT - General staging rules for clinical & pathological classifications - Staging systems in several chapters - Organization of T, N, M, and any additional categories into groups - Histologic classifications & grading systems - WHO histology codes - More illustrations - Extensive update to Version 9 Protocols of * Anus * Appendix * Brain and Spinal Cord * Cervix Uteri * NET Appendix, Colon & Rectum, Duodenum and Ampulla of Vater, Jejunum and Ileum, Pancreas, Stomach * Vulva NEW PARADIGMS - Human papillomavirus (HPV): oropharyngeal carcinoma staging systems based on HPV status - Separate staging systems for patients with neoadjuvant therapy (esophagus and stomach) NEW FEATURES - Levels of evidence provided for revisions to staging systems - Imaging section - Risk Assessment Models for select cancer sites - Recommendations for Clinical Trial Stratification - Prognostic factors - Required for prognostic stage grouping - Recommended for clinical care - Emerging factors NEW TOPICS/STAGING SYSTEMS - Risk Assessment Models - Cervical Nodes and Unknown Primary Tumors of the Head & Neck - Oropharynx, HPV-Mediated (p16+) - Cutaneous Carcinoma of the Head & Neck (includes cutaneous carcinoma of external lip) - Thymus - Bone: Appendicular Skeleton/Trunk/Skull/Face, Pelvis, & Spine - Soft Tissue Sarcoma of the Head & Neck, Trunk & Extremities, Abdomen & Thoracic Visceral Organs, Retroperitoneum, Unusual Histologies and Sites - Parathyroid - Leukemia Content licensed from printed ISBN 10: 3319406175 Content licensed from printed ISBN 13: 9783319406176 SUBSCRIPTION : Please purchase a yearly auto-renewing subscription to receive content access and available updates. Yearly auto-renewing payments- $79.99 Payment will be charged to your mode of payment you select at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your App “Settings” and tapping “Manage Subscriptions”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000 Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx Editor(s): Mahul B. Amin, MD, FCAP (Editor-in-Chief), Stephen B. Edge, MD, FACS, Frederick L. Greene, MD, FACS, et. al. Publisher: Springer-Verlag New York, Inc.